LIPS-A: Lung Injury Prevention Study With Aspirin
Location:
Rochester, Minn., Jacksonville, Fla.
Trial status:
Open for Enrollment
Why is this study being done?
This is a multi-center, phase, phase II double-blind, placebo-controled, randomized trial of aspirin for the prevention of acute lung injury in patients identified as at risk for acute lung injury.
NCT ID:
NCT01504867
IRB Number:
10-004856
Who can I contact for additional information about this study?
Rochester: Richard Hinds, MS 507-538-4344
Jacksonville: Kellie Ruday, RRT 904-953-2255